Source: Molecular Pharmaceutics. Unidade: ICB
Assunto: MICROBIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PORCHIA, Bruna Felicio Milazzotto Maldonado et al. Purified herpes simplex type 1 glycoprotein D (gD) genetically fused with the type 16 human papillomavirus E7 oncoprotein enhances antigen-specific CD8+ T Cell responses and confers protective antitumor immunity. Molecular Pharmaceutics, v. 8, n. 6, p. 2320-2330, 2011Tradução . . Disponível em: https://doi.org/10.1021/mp200194s. Acesso em: 13 maio 2024.APA
Porchia, B. F. M. M., Diniz, M. O., Cariri, F. A. M. O., Santana, V. C., Amorim, J. H., Balan, A., et al. (2011). Purified herpes simplex type 1 glycoprotein D (gD) genetically fused with the type 16 human papillomavirus E7 oncoprotein enhances antigen-specific CD8+ T Cell responses and confers protective antitumor immunity. Molecular Pharmaceutics, 8( 6), 2320-2330. doi:10.1021/mp200194sNLM
Porchia BFMM, Diniz MO, Cariri FAMO, Santana VC, Amorim JH, Balan A, Braga CJM, Ferreira LC de S. Purified herpes simplex type 1 glycoprotein D (gD) genetically fused with the type 16 human papillomavirus E7 oncoprotein enhances antigen-specific CD8+ T Cell responses and confers protective antitumor immunity [Internet]. Molecular Pharmaceutics. 2011 ; 8( 6): 2320-2330.[citado 2024 maio 13 ] Available from: https://doi.org/10.1021/mp200194sVancouver
Porchia BFMM, Diniz MO, Cariri FAMO, Santana VC, Amorim JH, Balan A, Braga CJM, Ferreira LC de S. Purified herpes simplex type 1 glycoprotein D (gD) genetically fused with the type 16 human papillomavirus E7 oncoprotein enhances antigen-specific CD8+ T Cell responses and confers protective antitumor immunity [Internet]. Molecular Pharmaceutics. 2011 ; 8( 6): 2320-2330.[citado 2024 maio 13 ] Available from: https://doi.org/10.1021/mp200194s